摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S,E)-tert-butyl 3-oxo-1,6-diphenylhex-4-en-2-ylcarbamate | 198208-01-4

中文名称
——
中文别名
——
英文名称
(S,E)-tert-butyl 3-oxo-1,6-diphenylhex-4-en-2-ylcarbamate
英文别名
tert-butyl (S,E)-3-oxo-1,6-diphenylhex-4-en-2-ylcarbamate;tert-butyl N-[(E,2S)-3-oxo-1,6-diphenylhex-4-en-2-yl]carbamate
(S,E)-tert-butyl 3-oxo-1,6-diphenylhex-4-en-2-ylcarbamate化学式
CAS
198208-01-4
化学式
C23H27NO3
mdl
——
分子量
365.472
InChiKey
SKKOTSANWYGBRM-QGRTWZNFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    530.765±50.00 °C(Press: 760.00 Torr)(predicted)
  • 密度:
    1.091±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    27
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (S,E)-tert-butyl 3-oxo-1,6-diphenylhex-4-en-2-ylcarbamate 在 palladium on activated charcoal sodium tetrahydroborate 、 sodium azide 、 18-冠醚-6氢气 、 sodium hydride 、 caesium carbonate甲基磺酰氯N,N-二异丙基乙胺间氯过氧苯甲酸红铝三氟乙酸 作用下, 以 四氢呋喃甲醇二氯甲烷二甲基亚砜1,2-二氯乙烷 为溶剂, 生成 SSS-2,5-diamino-1,6-diphenyl-3-hexanol
    参考文献:
    名称:
    Small hydroxyethylene-based peptidomimetics inhibiting both HIV-1 and C. albicans aspartic proteases
    摘要:
    We have extended a highly flexible method for rapidly assembling aspartic protease inhibitors to produce symmetric and asymmetric monohydroxyethylene peptidomimetics. This method is based on the prior synthesis of the central non-cleavable peptide-bond isostere [NH2-P(1psi)P1'-NH2; psi = hydroxyethylene isostere, HNCH(Bz)CHOHCH2CH(Bz)NH], with the possibility of accurately controlling its stereochemistry (S,S,S or S,R,S), and subsequently adding appropriate flanking units, chosen from commercially available amino acids, aromatic carboxylic acids, or phenoxyacetic acid (Poa) derivatives. The method was used to make asymmetric inhibitors of general formula Kyn-Xaa-PhepsiPhe-dmPoa, (Kyn = kynurenic acid, Xaa - Val, Thr or D-thienylglycine, M-r = 716-754) and symmetric inhibitors of formula xPoa-PhepsiPhe-xPoa (xPoa = Poa or dimethyl-, hydroxy-, formyl- or acetyl-Poa. Poa, M-r = 553-609). with logP(o/w). values ranging from 4.1 to 7.6. Inhibition of HIV-PR did not depend on the stereochemistry of the hydroxyl group, while it depended markedly on the substituents present on the Poa residues, with dmPoa being preferred over Poa or its more hydrophilic derivatives. Conversely, inhibition of Candida albicans Sap2 was higher for the S,S,S epimers, and Poa or its hydrophilic derivatives were preferred over dmPoa. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2003.08.004
  • 作为产物:
    参考文献:
    名称:
    Versatile and Stereoselective Synthesis of Diamino Diol Dipeptide Isosteres, Core Units of Pseudopeptide HIV Protease Inhibitors
    摘要:
    DOI:
    10.1021/jo971202p
点击查看最新优质反应信息

文献信息

  • Impact of Stereochemistry on Ligand Binding: X-ray Crystallographic Analysis of an Epoxide-Based HIV Protease Inhibitor
    作者:Fabio Benedetti、Federico Berti、Pietro Campaner、Lidia Fanfoni、Nicola Demitri、Folasade M. Olajuyigbe、Matteo De March、Silvano Geremia
    DOI:10.1021/ml500092e
    日期:2014.9.11
    A new pseudopeptide epoxide inhibitor, designed for irreversible binding to HIV protease (HIV-PR), has been synthesized and characterized in solution and in the solid state. However, the crystal structure of the complex obtained by inhibitor–enzyme cocrystallization revealed that a minor isomer, with inverted configuration of the epoxide carbons, has been selected by HIV-PR during crystallization.
    一种新的拟肽环氧化物抑制剂,设计用于与 HIV 蛋白酶 (HIV-PR) 的不可逆结合,已在溶液和固态中合成并表征。然而,通过抑制剂-酶共结晶获得的复合物的晶体结构表明,在结晶过程中,HIV-PR 选择了一种具有倒置环氧化物碳构型的次要异构体。有序假肽的结构表征,插入催化通道中,其环氧基团完整,提供了对抑制剂结合和 HIV-PR 立体选择性的更深入的了解,这有助于未来基于环氧化物的 HIV 抑制剂的开发。
  • Stereoselective Hydroazidation of Amino Enones:  Synthesis of the Ritonavir/Lopinavir Core
    作者:Ilaria Adamo、Fabio Benedetti、Federico Berti、Pietro Campaner
    DOI:10.1021/ol0524104
    日期:2006.1.1
    acid was found to proceed with high stereoselectivity in favor of the syn product. The stereoselectivity is controlled by the configuration of the enone and syn/anti ratios up to 7:1 were obtained with secondary and tertiary amines at low temperature. By this route the diamino alcohol core of HIV-PR inhibitors ritonavir and lopinavir was synthesized in 37% yield from phenylalanine.
    [反应:见正文]发现α'-氨基α,β-不饱和酮与原位生成的氢azo酸的碱催化加氢叠氮反应以高立体选择性进行,有利于合成产物。立体选择性由烯酮的构型控制,在低温下用仲胺和叔胺可获得高达7:1的顺/反比。通过这种途径,从苯丙氨酸以37%的产率合成了HIV-PR抑制剂利托那韦和洛匹那韦的二氨基醇核心。
  • A General and Highly Selective Chelate-Controlled Intermolecular Oxidative Heck Reaction
    作者:Jared H. Delcamp、Alexandria P. Brucks、M. Christina White
    DOI:10.1021/ja804120r
    日期:2008.8.27
    chelate-controlled intermolecular oxidative Heck reaction is reported that proceeds with a wide range of nonresonance stabilized alpha-olefin substrates and organoboron reagents to afford internal olefin products in good yields and outstanding regio- and E: Z stereoselectivities. Pd-H isomerization, common in many Heck reactions, is not observed under these mild, oxidative conditions. This is evidenced
    据报道,一种新型螯合物控制的分子间氧化 Heck 反应与各种非共振稳定的 α-烯烃底物和有机硼试剂一起进行,以良好的收率和出色的区域和 E:Z 立体选择性提供内烯烃产品。在许多 Heck 反应中常见的 Pd-H 异构化在这些温和的氧化条件下未观察到。这可以通过出色的 E:Z 选择性(在所有检查的情况下 >20:1)、近端立体中心的光学纯度没有侵蚀以及对未受保护的醇的耐受性来证明。值得注意的是,单一金属/配体组合,Pd/双-亚砜配合物 1,在广泛的偶联伙伴上催化该反应。鉴于高选择性和广泛的范围,
  • Versatile and Stereoselective Synthesis of Diamino Diol Dipeptide Isosteres, Core Units of Pseudopeptide HIV Protease Inhibitors
    作者:Fabio Benedetti、Stanislav Miertus、Stefano Norbedo、Alessandro Tossi、Pavel Zlatoidzky
    DOI:10.1021/jo971202p
    日期:1997.12.1
  • Small hydroxyethylene-based peptidomimetics inhibiting both HIV-1 and C. albicans aspartic proteases
    作者:Alessandro Tossi、Fabio Benedetti、Stefano Norbedo、Damiano Skrbec、Federico Berti、Domenico Romeo
    DOI:10.1016/j.bmc.2003.08.004
    日期:2003.11
    We have extended a highly flexible method for rapidly assembling aspartic protease inhibitors to produce symmetric and asymmetric monohydroxyethylene peptidomimetics. This method is based on the prior synthesis of the central non-cleavable peptide-bond isostere [NH2-P(1psi)P1'-NH2; psi = hydroxyethylene isostere, HNCH(Bz)CHOHCH2CH(Bz)NH], with the possibility of accurately controlling its stereochemistry (S,S,S or S,R,S), and subsequently adding appropriate flanking units, chosen from commercially available amino acids, aromatic carboxylic acids, or phenoxyacetic acid (Poa) derivatives. The method was used to make asymmetric inhibitors of general formula Kyn-Xaa-PhepsiPhe-dmPoa, (Kyn = kynurenic acid, Xaa - Val, Thr or D-thienylglycine, M-r = 716-754) and symmetric inhibitors of formula xPoa-PhepsiPhe-xPoa (xPoa = Poa or dimethyl-, hydroxy-, formyl- or acetyl-Poa. Poa, M-r = 553-609). with logP(o/w). values ranging from 4.1 to 7.6. Inhibition of HIV-PR did not depend on the stereochemistry of the hydroxyl group, while it depended markedly on the substituents present on the Poa residues, with dmPoa being preferred over Poa or its more hydrophilic derivatives. Conversely, inhibition of Candida albicans Sap2 was higher for the S,S,S epimers, and Poa or its hydrophilic derivatives were preferred over dmPoa. (C) 2003 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐